Corton Capital Inc. Amneal Pharmaceuticals, Inc. Transaction History
Corton Capital Inc.
- $81.2 Million
- Q2 2025
A detailed history of Corton Capital Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 15,542 shares of AMRX stock, worth $127,599. This represents 0.15% of its overall portfolio holdings.
Number of Shares
15,542
Previous 23,423
33.65%
Holding current value
$127,599
Previous $196,000
36.22%
% of portfolio
0.15%
Previous 0.67%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
246Shares Held
135MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$129 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$101 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$92.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$88.1 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$61.5 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.24B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...